Tomasz Glinka

1.2k total citations
29 papers, 942 citations indexed

About

Tomasz Glinka is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Tomasz Glinka has authored 29 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 11 papers in Pharmacology and 9 papers in Molecular Biology. Recurrent topics in Tomasz Glinka's work include Microbial Natural Products and Biosynthesis (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Quinazolinone synthesis and applications (5 papers). Tomasz Glinka is often cited by papers focused on Microbial Natural Products and Biosynthesis (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Quinazolinone synthesis and applications (5 papers). Tomasz Glinka collaborates with scholars based in United States and Poland. Tomasz Glinka's co-authors include Robert M. Williams, E. KWAST, Mieczysław Ma̧kosza, Juan F. Sanz‐Cervera, Scott J. Hecker, Jerzy T. Wróbel, Mark E. Flanagan, Janusz Popławski, Michael N. Dudley and David C. Griffith and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Tomasz Glinka

29 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Glinka United States 16 506 332 265 154 84 29 942
Mitsuko Asai Japan 19 570 1.1× 655 2.0× 517 2.0× 114 0.7× 53 0.6× 64 1.3k
A. D. Argoudelis United States 19 467 0.9× 617 1.9× 491 1.9× 51 0.3× 44 0.5× 70 1.2k
Shigetoshi Tsubotani Japan 18 325 0.6× 375 1.1× 253 1.0× 73 0.5× 42 0.5× 34 745
Keith H. Baggaley United Kingdom 18 319 0.6× 489 1.5× 306 1.2× 71 0.5× 89 1.1× 49 891
Robert B. Morin United States 13 334 0.7× 284 0.9× 249 0.9× 81 0.5× 28 0.3× 34 718
Tomoyuki Ishikura United Kingdom 19 388 0.8× 472 1.4× 503 1.9× 131 0.9× 29 0.3× 92 932
Hubert Maehr United States 18 444 0.9× 388 1.2× 312 1.2× 37 0.2× 23 0.3× 53 906
Khac‐Minh Thai Vietnam 19 371 0.7× 398 1.2× 206 0.8× 58 0.4× 64 0.8× 60 1.0k
Kenneth G. Hull United States 18 401 0.8× 396 1.2× 91 0.3× 67 0.4× 17 0.2× 41 788
Frank DiNinno United States 20 658 1.3× 279 0.8× 165 0.6× 83 0.5× 120 1.4× 43 1.1k

Countries citing papers authored by Tomasz Glinka

Since Specialization
Citations

This map shows the geographic impact of Tomasz Glinka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Glinka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Glinka more than expected).

Fields of papers citing papers by Tomasz Glinka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Glinka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Glinka. The network helps show where Tomasz Glinka may publish in the future.

Co-authorship network of co-authors of Tomasz Glinka

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Glinka. A scholar is included among the top collaborators of Tomasz Glinka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Glinka. Tomasz Glinka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hecker, Scott J., K. Raja Reddy, Olga Lomovskaya, et al.. (2020). Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases. Journal of Medicinal Chemistry. 63(14). 7491–7507. 158 indexed citations
2.
3.
Lemoine, Rémy C., Tomasz Glinka, William J. Watkins, et al.. (2004). Quinazolinone-based fungal efflux pump inhibitors. Part 1: Discovery of an (N-methylpiperazine)-containing derivative with activity in clinically relevant Candida spp.. Bioorganic & Medicinal Chemistry Letters. 14(20). 5127–5131. 17 indexed citations
4.
Glinka, Tomasz, Keith Huie, Aesop Cho, et al.. (2003). Relationships between structure, antibacterial activity, serum stability, pharmacokinetics and efficacy in 3-(heteroarylthio)cephems. Discovery of RWJ-333441 (MC-04,546). Bioorganic & Medicinal Chemistry. 11(4). 591–600. 7 indexed citations
5.
Hecker, Scott J., Trevor L. Calkins, Keith Huie, et al.. (2003). Prodrugs of Cephalosporin RWJ-333441 (MC-04,546) with Improved Aqueous Solubility. Antimicrobial Agents and Chemotherapy. 47(6). 2043–2046. 9 indexed citations
6.
Glinka, Tomasz. (2002). Novel cephalosporins for the treatment of MRSA infections.. PubMed. 3(2). 206–17. 9 indexed citations
7.
Cho, Aesop, et al.. (2001). New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position. Bioorganic & Medicinal Chemistry Letters. 11(2). 137–140. 9 indexed citations
8.
Hecker, Scott J., Tomasz Glinka, Aesop Cho, et al.. (2000). Discovery of RWJ-54428 (MC-02,479), a New Cephalosporin Active Against Resistant Gram-positive Bacteria.. The Journal of Antibiotics. 53(11). 1272–1281. 16 indexed citations
9.
Glinka, Tomasz, et al.. (2000). SAR Studies of Anti-MRSA Non-zwitterionic 3-Heteroarylthiocephems.. The Journal of Antibiotics. 53(10). 1045–1052. 6 indexed citations
10.
Ma̧kosza, Mieczysław, et al.. (1996). Vicarious nucleophilic substitution of hydrogen proceeding via heterocyclic ring opening. Tetrahedron. 52(9). 3189–3194. 8 indexed citations
11.
Ashton, Wallace T., Linda Chang, Nathan B. Mantlo, et al.. (1995). AT1/AT2-BALANCED ANGIOTENSIN II ANTAGONISTS. European Journal of Medicinal Chemistry. 30. 255s–266s. 5 indexed citations
12.
Glinka, Tomasz, Stephen E. de Laszlo, Raymond S.L. Chang, et al.. (1994). L-161,638: A potent AT2selective quinazolinone angiotensin II binding inhibitor. Bioorganic & Medicinal Chemistry Letters. 4(12). 1479–1484. 11 indexed citations
13.
Sanz‐Cervera, Juan F., Tomasz Glinka, & Robert M. Williams. (1993). Biosynthesis of the brevianamides: quest for a biosynthetic Diels-Alder cyclization. Journal of the American Chemical Society. 115(1). 347–348. 45 indexed citations
14.
Sanz‐Cervera, Juan F., Tomasz Glinka, & Robert M. Williams. (1993). Biosynthesis of brevianamides A and B: in search of the biosynthetic diels-alder construction. Tetrahedron. 49(38). 8471–8482. 51 indexed citations
15.
Williams, Robert M., et al.. (1992). Cannizzaro-based O2-dependent cleavage of DNA by quinocarcin. Journal of the American Chemical Society. 114(2). 733–740. 65 indexed citations
16.
Williams, Robert M., et al.. (1991). Synthesis, conformation, crystal structures and DNA cleavage abilities of tetracyclic analogs of quinocarcin. Tetrahedron. 47(14-15). 2629–2642. 20 indexed citations
17.
Williams, Robert M., et al.. (1990). Asymmetric, stereocontrolled total synthesis of (-)-brevianamide B. Journal of the American Chemical Society. 112(2). 808–821. 130 indexed citations
18.
Williams, Robert M., Tomasz Glinka, & E. KWAST. (1988). Facial selectivity of the intramolecular SN2' cyclization: stereocontrolled total synthesis of brevianamide B. Journal of the American Chemical Society. 110(17). 5927–5929. 65 indexed citations
19.
Ma̧kosza, Mieczysław & Tomasz Glinka. (1983). Reaction of organic anions. Part 108. On the mechanism of the vicarious nucleophilic substitution of hydrogen in nitroarenes. The Journal of Organic Chemistry. 48(21). 3860–3861. 54 indexed citations
20.
Popławski, Janusz, Jerzy T. Wróbel, & Tomasz Glinka. (1980). Panaxydol, a new polyacetylenic epoxide from Panax ginseng roots. Phytochemistry. 19(7). 1539–1541. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuko Asai Breakdown of academic impact, for papers by A. D. Argoudelis Breakdown of academic impact, for papers by Shigetoshi Tsubotani Breakdown of academic impact, for papers by Keith H. Baggaley Breakdown of academic impact, for papers by Robert B. Morin Breakdown of academic impact, for papers by Tomoyuki Ishikura Breakdown of academic impact, for papers by Hubert Maehr Breakdown of academic impact, for papers by Khac‐Minh Thai Breakdown of academic impact, for papers by Kenneth G. Hull Breakdown of academic impact, for papers by Frank DiNinno
Rankless by CCL
2026